Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-015019
Filing Date
2026-05-06
Accepted
2026-05-06 08:05:18
Documents
93
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20260331_10q.htm   iXBRL 10-Q 1776084
2 EXHIBIT 10.1 ex_941915.htm EX-10.1 1323870
3 EXHIBIT 31.1 ex_941916.htm EX-31.1 16975
4 EXHIBIT 31.2 ex_941917.htm EX-31.2 16981
5 EXHIBIT 32.1 ex_941918.htm EX-32.1 6549
6 EXHIBIT 32.2 ex_941919.htm EX-32.2 6549
  Complete submission text file 0001437749-26-015019.txt   9796491

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20260331.xsd EX-101.SCH 80396
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20260331_cal.xml EX-101.CAL 60629
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20260331_def.xml EX-101.DEF 470057
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20260331_lab.xml EX-101.LAB 435438
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20260331_pre.xml EX-101.PRE 515863
97 EXTRACTED XBRL INSTANCE DOCUMENT urgn20260331_10q_htm.xml XML 1146556
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 26945892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)